244 related articles for article (PubMed ID: 4036448)
21. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
Raut S; Gaffney PJ
Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
[TBL] [Abstract][Full Text] [Related]
22. Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product.
Hishikawa-Itoh Y; Sugie I; Kato H; Iwanaga S
J Biochem; 1982 Oct; 92(4):1129-40. PubMed ID: 6890955
[TBL] [Abstract][Full Text] [Related]
23. Soluble fibrin complexes: separation as a function of pH and characterization.
Benabid Y; Concord E; Suscillon M
Thromb Haemost; 1977 Feb; 37(1):144-53. PubMed ID: 14416
[TBL] [Abstract][Full Text] [Related]
24. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
Gramse M; Bingenheimer C; Schmidt W; Egbring R; Havemann K
J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
[TBL] [Abstract][Full Text] [Related]
25. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
26. [Electrophoretic fractions and NH2-terminal amino acids of high-molecular tryptic fragments of fibrinogen and fibrin].
Lugovskoĭ EV; Pozdniakova TM; Varetskaia TV; Derzskaia SG; Tolstykh VM
Ukr Biokhim Zh; 1976; 48(6):743-9. PubMed ID: 1014141
[TBL] [Abstract][Full Text] [Related]
27. [The role of D2-E2 centers of interdomain binding of fibrin monomer during fibrinogen co-polymerization with an NH2-terminal disulfide knot of fibrin].
Pozdniakova TM; Rybachuk VN; Ugarova TP
Biokhimiia; 1987 Apr; 52(4):592-8. PubMed ID: 3593791
[TBL] [Abstract][Full Text] [Related]
28. Isolation of fibrinogen A alpha-chain by affinity chromatography on concanavalin A-sepharose.
Bögli C; Hofer A; Furlan M
Thromb Haemost; 1988 Oct; 60(2):308-10. PubMed ID: 3217923
[TBL] [Abstract][Full Text] [Related]
29. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
[TBL] [Abstract][Full Text] [Related]
30. Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
Kinjoh K; Nakamura M; Sunagawa M; Kosugi T
Haematologia (Budap); 2002; 32(4):457-65. PubMed ID: 12803119
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
[TBL] [Abstract][Full Text] [Related]
32. Normal plasmic cleavage of the gamma-chain variant of "fibrinogen Saga" with an Arg-275 to His substitution.
Yamazumi K; Terukina S; Onohara S; Matsuda M
Thromb Haemost; 1988 Dec; 60(3):476-80. PubMed ID: 2976995
[TBL] [Abstract][Full Text] [Related]
33. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
[TBL] [Abstract][Full Text] [Related]
34. Fibrin degradation products. A review of structures found in vitro and in vivo.
Gaffney PJ
Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
[TBL] [Abstract][Full Text] [Related]
35. [The effect of calcium 2+ ions on the decomposition of canine and human fibrin(ogen) by (human) plasmin].
Wolling H; Mischke R
Berl Munch Tierarztl Wochenschr; 1995 Oct; 108(10):373-9. PubMed ID: 7495409
[TBL] [Abstract][Full Text] [Related]
36. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
Cierniewski CS; Kloczewiak M; Budzynski AZ
J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
[TBL] [Abstract][Full Text] [Related]
37. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
[TBL] [Abstract][Full Text] [Related]
38. Localization of a fibrin gamma-chain polymerization site within segment Thr-374 to Glu-396 of human fibrinogen.
Horwitz BH; Váradi A; Scheraga HA
Proc Natl Acad Sci U S A; 1984 Oct; 81(19):5980-4. PubMed ID: 6592597
[TBL] [Abstract][Full Text] [Related]
39. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of the fragment D-fibrin monomer complex formation by salting-out fractionation].
Pozdniakova TM; Rybachuk VN; Vovk Ev
Biokhimiia; 1982 Jun; 47(6):971-6. PubMed ID: 7115809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
